Auxilium (AUXL) Clarifies CEO Inducement Grant Under Nasdaq Rule 5635(c)(4)
Tweet
Share
E-mailGet Alerts AUXL Hot Sheet
Join SI Premium – FREE
Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL), reported a clarification regarding the classification under the NASDAQ Listing Rules of an option to purchase shares of Auxilium common stock previously granted to Auxilium's Chief Executive Officer and President, Adrian Adams.
On December 8, 2011, Auxilium announced the hiring of Mr. Adams and the award to Mr. Adams of an option to purchase 550,000 shares of Auxilium's common stock (the "Adams Grant"). Today, the Company clarified the classification of the Adams Grant under the NASDAQ Listing Rules. 500,000 shares (the "Plan Shares") underlying the Adams Grant were granted under Auxilium's 2004 Equity Compensation Plan, as amended and restated (the "Plan") and 50,000 shares (the "Inducement Shares") underlying the Adams Grant were granted outside of the Plan. Auxilium granted the Inducement Shares as an inducement material to Mr. Adams' entering into employment with Auxilium, pursuant to NASDAQ Listing Rule 5635(c)(4).
On December 8, 2011, Auxilium announced the hiring of Mr. Adams and the award to Mr. Adams of an option to purchase 550,000 shares of Auxilium's common stock (the "Adams Grant"). Today, the Company clarified the classification of the Adams Grant under the NASDAQ Listing Rules. 500,000 shares (the "Plan Shares") underlying the Adams Grant were granted under Auxilium's 2004 Equity Compensation Plan, as amended and restated (the "Plan") and 50,000 shares (the "Inducement Shares") underlying the Adams Grant were granted outside of the Plan. Auxilium granted the Inducement Shares as an inducement material to Mr. Adams' entering into employment with Auxilium, pursuant to NASDAQ Listing Rule 5635(c)(4).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
- Lazard Global Total Return fund declares $0.1534 monthly distribution
Create E-mail Alert Related Categories
Corporate News, Insider TradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
